BridgeBio Pharma
BBIO
#1405
Rank
S$19.10 B
Marketcap
S$98.08
Share price
-2.75%
Change (1 day)
10.26%
Change (1 year)

Market capitalization of BridgeBio Pharma (BBIO)

Market cap: S$19.10 Billion

As of November 2026 BridgeBio Pharma has a market cap of S$19.10 Billion. This makes BridgeBio Pharma the world's 1405th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BridgeBio Pharma from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026S$19.10 B-0.11%
2025S$19.12 B169.85%
2024S$7.08 B-23.58%
2023S$9.27 B507.41%
2022S$1.52 B-53.99%
2021S$3.31 B-71.25%
2020S$11.54 B97.54%
2019S$5.84 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of BridgeBio Pharma was reported to be:

S$19.10 Billion
by Nasdaq info icon info icon
S$19.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
S$1.50 B-92.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S$26.96 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA